Tissue engineering with electroporation
Handbook of Electroporation, Vol: 3, Page: 1579-1599
2017
- 8Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures8
- Readers8
Book Chapter Description
Organ failure and the demand for donor organs for transplantation has resulted in recent progress within the field of tissue engineering and increased functionality in the development of tissues and whole organs. This complex field brings together many different techniques and technologies in an attempt to build a tissue construct that can support cell growth and fully integrate into the body after transplantation. Electroporation is one technology that has been applied towards various applications within the field of tissue engineering. For example, nonthermal irreversible electroporation (NTIRE) has been shown as a potential method for tissue decellularization, producing tissue- and organ-derived scaffolds by removing the cellular content while preserving important structural and biochemical features to support cell growth. This method has been applied both in vivo and ex vivo with the use of active perfusion. In addition, nonthermal irreversible electroporation (NTIRE) has been applied to develop natural scaffolds with controlled porosity to enable the development of vasculature within the newly developing tissue, allowing for nutrients to be delivered throughout. Reversible electroporation (RE) has also shown potential for applications within the field of tissue engineering. By creating temporary pores within the cell membrane, reversible electroporation can be used for gene transfection, resulting in transfected cells that express growth factors needed for vasculature development and also having applications for stem cell differentiation. With further research, these areas of electroporation may develop into impactful technologies for the field of tissue engineering.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85044048726&origin=inward; http://dx.doi.org/10.1007/978-3-319-32886-7_49; http://link.springer.com/10.1007/978-3-319-32886-7_49; https://dx.doi.org/10.1007/978-3-319-32886-7_49; https://link.springer.com/referenceworkentry/10.1007/978-3-319-32886-7_49
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know